1 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Artbio Competitors or Alternatives

Artbio's top competitors include POINT, Fusion Pharma and Orano Med.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Artbio's company profile

Emanuele Ostuni

CEO

90/100
1 - 25
$113M
$100K - 5M
  • $113M
    $100K - 5M
  • 1 - 25
    $113M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $113M
  • $100K - 5M
View ProfileView
1
Artbio's Competitor - POINT logo

Joe McCann

CEO

90/100
129
$155M
$11.2M
  • $155M
    $11.2M
  • 129
    $155M
  • $11.2M
  • 90/100
  • 129
  • $155M
  • $11.2M
View ProfileView
2
Artbio's Competitor - Fusion Pharma logo

John Valliant

CEO

90/100
113
$363.5M
$2.1M
  • $363.5M
    $2.1M
  • 113
    $363.5M
  • $2.1M
  • 90/100
  • 113
  • $363.5M
  • $2.1M
View ProfileView
3
Artbio's Competitor - Orano Med logo

Patrick Bourdet

Founder

- -
$326M
  • $326M
  • $326M
  • - -
  • $326M
View ProfileView
4
Artbio's Competitor - QBioMed logo

Denis D. Corin

Chairman & CEO

67/100
7
$10.1M
$ < 1M
  • $10.1M
    $ < 1M
  • 7
    $10.1M
  • $ < 1M
  • 67/100
  • 7
  • $10.1M
  • $ < 1M
View ProfileView
5
Artbio's Competitor - SpaceOAR logo

CEO

- -
100 - 250
$46.7M
$5M - 25M
  • $46.7M
    $5M - 25M
  • 100 - 250
    $46.7M
  • $5M - 25M
  • - -
  • 100 - 250
  • $46.7M
  • $5M - 25M
View ProfileView
Artbio's top 16 competitors are POINT, Fusion Pharma, Orano Med, Telix, QBioMed, SpaceOAR, RayzeBio, Athenex, ARMO BioSciences, Progenics, Clovis Oncology, Y-mAbs, Actinium, RadioMedix, Novartis and Lantheus. Together they have raised over 3.8B between their estimated 78.3K employees. Artbio's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 3.5B. Artbio has 15 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 4,895.

Artbio VS POINT

POINT is Artbio's #1 rival. POINT was founded in 2019 in Toronto, Ontario. Like Artbio, POINT also operates in the Pharmaceuticals space. POINT generates $9.4M more revenue than Artbio.

Artbio VS Fusion Pharma

Fusion Pharma is one of Artbio's top competitors. Fusion Pharma is headquartered in Hamilton, Ontario, and was founded in 2014. Like Artbio, Fusion Pharma also works within the Pharmaceuticals sector. Fusion Pharma generates 116% the revenue of Artbio.

Artbio VS Orano Med

Orano Med is seen as one of Artbio's top competitors. Orano Med was founded in 2009, and its headquarters is in Plano, Texas. Like Artbio, Orano Med also works within the Pharmaceuticals & Biotechnology sector. Orano Med has NaN fewer employees than Artbio.

Looking for similar companies to Artbio?

Similar Companies

Pharmaceuticals companies in Sacramento

See 14 companies 
Pharmaceuticals companies in Sacramento Metropolitan Area

See 42 companies 
Pharmaceuticals & Biotechnology companies in Sacramento

See 31 companies 
Pharmaceuticals & Biotechnology companies in Sacramento Metropolitan Area

See 115 companies 
Companies in Sacramento with employees in 1-25 range

See 777 companies 
Pharmaceuticals companies in California

See 1,457 companies 
Companies in Sacramento with revenue in $100K-5.0M range

See 1,947 companies 
Pharmaceuticals companies with employees in 1-25 range

See 2,166 companies 
Pharmaceuticals companies with revenue in $100K-5.0M range

See 2,203 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Artbio and Artbio's Competitors

Today 5:37 AMBenzinga
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharma...
April 15, 2025StreetInsider
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) tod...
April 15, 2025Powder and Bulk Solids
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....
Today 10:20 PMPharmaceutical Processing World
Bayer announced today that it opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility. The grand opening of the state-of-the-art...
April 15, 2025Benzinga
LOS ANGELES, April 15, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Actinium Pharmaceuticals, Inc. ("Actinium " or the "Company") ATNM investo...
April 15, 2025FinanzNachrichten
MELBOURNE, Australia, April 15, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its...
April 14, 2025Boston Real Estate Times
East Hanover, N.J. - In a major show of commitment to its largest market, global pharmaceutical giant Novartis announced on Wednesday a sweeping $23 bi...
April 15, 2025Benzinga
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. ATNM . Sh...
April 14, 2025Openpr
A new study titled Chronic Myeloid Leukemia Treatment Market 2024, published by the Coherent Market Insights, offers information on regional and global...
April 14, 2025Njherald
Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced pla...

Frequently Asked Questions about Artbio

  1. Who are Artbio's top competitors?

    Artbio's top 3 competitors are POINT, Fusion Pharma, Orano Med.

  2. Who is similar to Artbio?

    POINT is the most similar to Artbio. Fusion Pharma and Orano Med are also similar to Artbio.

  1. Are Artbio and POINT competitors?

    Yes, POINT is one of Artbio’s top competitors.